UnknownNot Applicable

ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.

Italy1,800 participantsStarted 2019-09-01

Plain-language summary

The study assesses the impact on quality of care of implementing the ERAS (Enhanced Recovery After Surgery) protocol for hysterectomy of benign or malignant tumors of the uterus in the network of public hospitals in the Regione Piemonte (North-West Italy). Every hospital is a cluster entering the study treating patients according to its current clinical practice. On the basis of a randomized order, each hospital switches from current clinical practice to the adoption of the ERAS protocol.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All the hospital wards within the Piemonte Region performing hysterectomy. * All the patients receiving an elective hysterectomy for benign or malignant tumors of the uterus. Exclusion Criteria: * Hospital wards performing less than 20 expected cases per year * Emergency hysterectomy * Hysterectomy for pelvic floor disorders * High severity cases not allowing ERAS protocol implementation (i.e. American Society of Anesthesiologists score: ASA V).

What they're measuring

Length of stay

Timeframe: 12 days after admission

Trial details

NCT IDNCT04063072

SponsorOspedale Regina Montis Regalis

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07-31

Contact for this trial

Andrea Puppo, MD

0039 0174677 andrea.puppo@aslcn1.it

View on ClinicalTrials.gov More Uterine Neoplasms trials